Clinicians are currently using TRIPP to help immerse patients into alternative realities and to support patients’ wellbeing before, during, and after ketamine-assisted therapy.
Study authors write, “Results showed significant and large reductions in the intensity of traumatic stress, depression, and anxiety symptoms from the 30 days before to the 30 days after a referent psychedelic experience.”
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.